Middle-East and Africa Clinical Clinical Trial Imaging Market Expanding at a Stable CAGR of 6.1% from 2016 to 2022
Middle East and Africa clinical trial imaging market Information, by Products (Services, Software, and others), by Modality (X-Ray, Ultrasound, CT, PET, MRI, Echocardiography, and others), by End Users (pharmaceutical companies, biotech companies, research centers, hospitals and others) – Forecast to 2022
Pune, India – August 24, 2017 /MarketersMedia/ —
Market Highlights
The Middle-East and Africa Clinical trial imaging Market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Clinical trial is major process in drug development process. Drug development process is expensive and need huge funding. Imaging perform different functions in clinical trials like detection, characterization, and monitoring or assessment. Pharmaceutical and biotechnology companies investing in R&D to develop new drugs which further observed and make available to the public. Imaging also plays important role to minimize the cost of clinical trials. Imaging is a natural fit for early phase trials, since they are more dynamic and involve more scientific work than later-phase trials. Imaging biomarkers to increase the probability of success in clinical trials and to evaluate efficacy more rapidly. Increasing number of non-communicable diseases, improved healthcare infrastructure, and government initiatives are leading the growth for clinical trial imaging market in Middle East and Africa. However, there are some factors affecting the growth for clinical trial imaging market in Middle East and Africa such as inaccurate data collection, improper data sharing, expensive drug development process, limited access to the advance imaging technology, delays in trial, strict government regulations etc.
Middle-East and Africa Clinical trial imaging Market was estimated of US$ 76.1 million in 2015 and expected to reach US$ 115.6 million by 2022 at a CAGR of 6.1%.
Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/2580
Key Players for Middle East and Africa clinical trial imaging market:
• Bioclinica, Inc. (US),
• Cardiovascular Imaging Technologies, LLC (US),
• Parexel International Corporation (US),
• Biomedical Systems Corporation (US),
• Icon PLC (Republic of Ireland),
• Intrinsic Imaging LLC (US),
• Biotelemetry, Inc. (US),
• Intrinsic Imaging LLC (US),
• Parexel International Corporation (US).
Commenting on the report, an analyst from Market Research Future (MRFR)’s team said: The market for Middle-East and Africa Clinical trial imaging is growing moderately and expected to continue its growth similarly in near future. Clinical trial is major part of drug development process. Imaging was identified as one of the components that could play an important role in reducing the cost of clinical trials. Imaging plays important role in clinical trials, such as detection, characterization, and monitoring or assessment. Increasing number of pharmaceutical and biotechnology companies and demand for new drugs are driving the growth for the Middle-East and Africa Clinical trial imaging market. These pharmaceutical and biotechnology companies spending huge amount of money in research and development of drug which observed after therapy and make available to the public. Clinical trials are very important process to observe and research the results occurred after therapy. Increasing per capita income, expenditure on healthcare, excellent infrastructure and quality facilities are driving the growth for overall healthcare sector in Middle-East and Africa. Cases of non-commutable diseases such as heart diseases, diabetes, and stoke are increasing rapidly in Middle East and Africa region. Middle East and Africa region is also facing the issue of increasing cancer patients.
Access Report Details @ https://www.marketresearchfuture.com/reports/clinical-trial-imaging-market-2580
Segmentation
Middle East and Africa clinical trial imaging market has been segmented
On the basis of products
• Services
• Software
• others.
On the basis of modality
• X-Ray
• Ultrasound
• CT
• PET
• MRI
• Echocardiography
• others.
On the basis of end user
• pharmaceutical companies
• biotech companies
• research centers
• hospitals
• others
Related Report
Ambulatory Services Market information, by type (Hospital emergency departments (EDs), Primary care offices, Hospital-based outpatient departments (OPDs), physician private practices, Community Health Centers, Ambulatory surgery centers (ASCs), Urgent Care Centers, and Others) – Forecast to 2022.Know more about this report @ https://www.marketresearchfuture.com/reports/ambulatory-services-market-2491
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Magarpatta Road, Hadapsar,
Phone: 6468459349
For more information, please visit https://www.marketresearchfuture.com
Source: MarketersMedia
Release ID: 230745
Copyright © 1999-2013 SproutNews.com
